120 related articles for article (PubMed ID: 26413023)
1. Plasma Exchange for Urgent Apixaban Reversal in a Case of Hemorrhagic Tamponade after Pacemaker Implantation.
Lam WW; Reyes MA; Seger JJ
Tex Heart Inst J; 2015 Aug; 42(4):377-80. PubMed ID: 26413023
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous splenic rupture associated with apixaban: a case report.
Lowry LE; Goldner JA
J Med Case Rep; 2016 Aug; 10(1):217. PubMed ID: 27506776
[TBL] [Abstract][Full Text] [Related]
3. Lessons for the clinical nephrologist: acute kidney injury during therapy with apixaban.
Vischini G; Speciale S; Przygocka A; Martano L; La Manna G; Baraldi O
J Nephrol; 2024 Mar; 37(2):511-513. PubMed ID: 38055150
[No Abstract] [Full Text] [Related]
4. Apixaban-Induced Spontaneous Hemorrhagic Cardiac Tamponade.
Ambat J; Patel S; Pathak PR; Antony M; Basu AK; Sto Domingo FG; Vu PQ
Cureus; 2024 Mar; 16(3):e55476. PubMed ID: 38571853
[TBL] [Abstract][Full Text] [Related]
5. Complete investigations (autopsy, toxicology, and histology) in a death due to apixaban overdose.
Kintz P; Allain C; Oertel L; Feisthauer E; Ameline A; Raul JS
Int J Legal Med; 2023 Nov; 137(6):1743-1750. PubMed ID: 37542673
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous Hemorrhagic Pericardial Effusion as a Consequence of Apixaban Utilization for New-Onset Atrial Fibrillation.
Trivedi D; Lorenzana AM; Bronchard K; Reddy B
Cureus; 2024 Mar; 16(3):e56510. PubMed ID: 38646361
[TBL] [Abstract][Full Text] [Related]
7. Prescribing patterns of target-specific oral anticoagulants: an academic hospital perspective.
Johnson SA; Yarbrough PM; Rose RS; Lanspa MJ
Blood Coagul Fibrinolysis; 2015 Oct; 26(7):767-71. PubMed ID: 26414695
[TBL] [Abstract][Full Text] [Related]
8. To Bleed or Not to Bleed: That is the Question. The Side Effects of Apixaban.
Ciccone MM; Zito A; Devito F; Maiello M; Palmiero P
Curr Drug Targets; 2018; 19(6):581-584. PubMed ID: 26424386
[TBL] [Abstract][Full Text] [Related]
9. Laboratory measurement of the direct oral anticoagulants.
Dale BJ; Chan NC; Eikelboom JW
Br J Haematol; 2016 Feb; 172(3):315-36. PubMed ID: 26492202
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation.
Lip GY; Lanitis T; Kongnakorn T; Phatak H; Chalkiadaki C; Liu X; Kuznik A; Lawrence J; Dorian P
Clin Ther; 2015 Nov; 37(11):2476-2488.e27. PubMed ID: 26477648
[TBL] [Abstract][Full Text] [Related]
11. Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants.
Chan NC; Bhagirath V; Dale BJ; Eikelboom JW
Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1213-23. PubMed ID: 26471327
[TBL] [Abstract][Full Text] [Related]
12. Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
Durheim MT; Cyr DD; Lopes RD; Thomas LE; Tsuang WM; Gersh BJ; Held C; Wallentin L; Granger CB; Palmer SM; Al-Khatib SM
Int J Cardiol; 2016 Jan; 202():589-94. PubMed ID: 26447668
[TBL] [Abstract][Full Text] [Related]
13. Measurement of Anti-Factor Xa Activity in Patients on Apixaban for Non-Valvular Atrial Fibrillation.
Osanai H; Ajioka M; Masutomi T; Kuwayama T; Ishihama S; Sakamato Y; Otaka N; Sakaguchi T; Inoue Y; Kanbara T; Nakashima Y; Asano H; Sakai K
Circ J; 2015; 79(12):2584-90. PubMed ID: 26439323
[TBL] [Abstract][Full Text] [Related]
14. Apixaban (Eliquis) in deep vein thrombosis and pulmonary embolism. Warfarin remains the standard therapy.
Prescrire Int; 2015 Sep; 24(163):206. PubMed ID: 26417627
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis of Efficacy and Safety of Apixaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
Lu D; Liu Q; Wang K; Zhang QI; Shan QJ
Pacing Clin Electrophysiol; 2016 Jan; 39(1):54-9. PubMed ID: 26495799
[TBL] [Abstract][Full Text] [Related]
16. Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation.
Weitz JI; Eikelboom J
Thromb Haemost; 2016 Jan; 115(2):257-70. PubMed ID: 26466666
[TBL] [Abstract][Full Text] [Related]
17. Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014.
Weitz JI; Semchuk W; Turpie AG; Fisher WD; Kong C; Ciaccia A; Cairns JA
Clin Ther; 2015 Nov; 37(11):2506-2514.e4. PubMed ID: 26481493
[TBL] [Abstract][Full Text] [Related]
18. Extended anticoagulation with apixaban reduces hospitalisations in patients with venous thromboembolism. An analysis of the AMPLIFY-EXT trial.
Liu X; Thompson J; Phatak H; Mardekian J; Porcari A; Johnson M; Cohen AT
Thromb Haemost; 2016 Jan; 115(1):161-8. PubMed ID: 26446706
[TBL] [Abstract][Full Text] [Related]
19. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
[TBL] [Abstract][Full Text] [Related]
20. [Direct oral anticoagulation and gastrointestinal bleeding: Interventional therapy management].
Braun G; Messmann H; Labenz J; Buerke M
Med Klin Intensivmed Notfmed; 2015 Oct; 110(7):510-4. PubMed ID: 26420063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
